Issued Patents All Time
Showing 1–25 of 41 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12403180 | Interleukin-18 variants and methods of use | Ting Zhou, Suzanne Fischer | 2025-09-02 |
| 12343379 | Interleukin-18 variants and methods of use | Ting Zhou, Suzanne Fischer | 2025-07-01 |
| 12233093 | Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling | Judith A. Shizuru, Irving L. Weissman, Kipp Andrew Weiskopf, Akanksha Chhabra, Peter Schnorr | 2025-02-25 |
| 12202873 | Superagonists, partial agonists and antagonists of interleukin-2 | Christopher K. Garcia, Suman Mitra, Warren J. Leonard | 2025-01-21 |
| 12195532 | High affinity SIRP-alpha reagents and methods of using | Kenan Christopher Garcia, Kipp Andrew Weiskopf, Aron Levin, Irving L. Weissman | 2025-01-14 |
| 12091455 | Compositions for modulation of a TREM or TREML protein and methods of use | Andrew Wang, Wenjun Liu | 2024-09-17 |
| 12029778 | Interleukin-18 mimics and methods of use | — | 2024-07-09 |
| 12006347 | Superagonists and antagonists of interleukin-2 | Kenan Christopher Garcia, Aron Levin | 2024-06-11 |
| 11850276 | Interleukin-18 variants and methods of use | Tom Boone | 2023-12-26 |
| 11814419 | High affinity PD-1 agents and methods of use | Andrew Kruse, Aashish Manglik, Irving L. Weissman, Roy Louis Maute, Melissa N. McCracken +1 more | 2023-11-14 |
| 11718675 | Disrupting FC receptor engagement on macrophages enhances efficacy of anti-SIRPalpha antibody therapy | Jie Liu, Jens-Peter Volkmer, Irving L. Weissman | 2023-08-08 |
| 11668021 | Basehit, a high-throughput assay to identify proteins involved in host-microbe interaction | Connor Rosen, Noah Palm | 2023-06-06 |
| 11459388 | Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance | Roy Louis Maute, Kipp Andrew Weiskopf, Irving L. Weissman | 2022-10-04 |
| 11419897 | Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling | Judith A. Shizuru, Irving L. Weissman, Kipp Andrew Weiskopf, Akanksha Chhabra, Peter Schnorr | 2022-08-23 |
| 11407801 | SIRP-gamma polypeptide compositions and treatment of cancer | Roy Louis Maute, Andrew Kruse, Aashish Manglik, Kenneth Lin | 2022-08-09 |
| 11384131 | Superagonists, partial agonists and antagonists of interleukin-2 | Christopher K. Garcia, Suman Mitra, Warren J. Leonard | 2022-07-12 |
| 11208481 | High affinity SIRP-alpha reagents and methods of using | Kenan Christopher Garcia, Kipp Andrew Weiskopf, Aron Levin, Irving L. Weissman | 2021-12-28 |
| 11117943 | Superagonists and antagonists of interleukin-2 | Kenan Christopher Garcia, Aron Levin | 2021-09-14 |
| 11041868 | Compositions comprising G protein-coupled receptors maintained in a conformationally selective manner by a modulator | Aashish Manglik, Andrew Kruse, Brian Kobilka | 2021-06-22 |
| 10934331 | Methods for enhancing immune responsiveness in an individual toward a target cancer cell population comprising apoptotic cells | Daniel Mark COREY, Melissa N. McCracken, Irving L. Weissman | 2021-03-02 |
| 10889649 | Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance | Roy Louis Maute, Kipp Andrew Weiskopf, Irving L. Weissman | 2021-01-12 |
| 10829771 | Compositions and methods for expressing polypeptides on the surface of cells | Andrew Kruse, Aashish Manglik | 2020-11-10 |
| 10800830 | High affinity PD-1 agents and methods of use | Andrew Kruse, Aashish Manglik, Irving L. Weissman, Roy Louis Maute, Melissa N. McCracken +1 more | 2020-10-13 |
| 10781256 | Anti SIRP-α antibodies and bi-specific macrophage enhancing antibodies | Kipp Andrew Weiskopf, Jens-Peter Volkmer, Irving L. Weissman, Nan Guo Ring | 2020-09-22 |
| 10774125 | SIRP-gamma polypeptide compositions and methods of use | Roy Louis Maute, Andrew Kruse, Aashish Manglik, Kenneth Lin | 2020-09-15 |